Glucose intolerance and serum aminotransferase activities in Japanese men

Journal of Hepatology

Volumn 38, Issue 1, 2003, Pages 18-23

  Miyake, Yumi ^a   Eguchi, Hiroyuki ^a,b   Shinchi, Koichi ^c   Oda, Takashi ^c   Sasazuki, Shizuka ^a   Kono, Suminori ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Self Defense Forces Fukuoka Hospital   (Japan)

^c Self Defense Forces Kumamoto Hospital   (Japan)

Author keywords

Diabetes mellitus; Impaired glucose tolerance; Japanese men; Serum aminotransferase

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; JAPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ASIAN CONTINENTAL ANCESTRY GROUP; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; DIABETES MELLITUS; FASTING; GAMMA-GLUTAMYLTRANSFERASE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; JAPAN; MALE; MIDDLE AGED; ODDS RATIO;

EID: 0037230441     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00323-9     Document Type: Article

References (41)

1. Reichling JJ, Kaplan MM. Clinical use of serum enzymes in liver disease. Dig Dis Sci 1988;33:1601-1614.
2. Sherman KE. Alanine aminotransferase in clinical practice. A review. Arch Intern Med 1991;151:260-265.
3. Byron D, Minuk GY. Clinical hepatology: profile of an urban, hospital-based practice. Hepatology 1996;24:813-815.
4. Salvaggio A, Periti M, Miano L, Tavanelli M, Marzorati D. Body mass index and liver enzyme activity in serum. Clin Chem 1991;37:720-723.
5. Lozano M, Cid J, Bedini JL, Mazzara R, Gimenez N, Mas E, et al. Study of serum alanine-aminotransferase levels in blood donors in Spain. Haematologica 1998;83:237-239.
6. James OF, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 1998;29:495-501.
7. James O, Day C. Non-alcoholic steatohepatitis: another disease of affluence. Lancet 1999;353:1634-1636.
8. Salmela PI, Sotaniemi EA, Niemi M, Maentausta O. Liver function tests in diabetic patients. Diabetes Care 1984;7:248-254.
9. Nagore N, Scheuer PJ. The pathology of diabetic hepatitis. J Pathol 1988;156:155-160.
10. Silverman JF, O'Brien KF, Long S, Leggett N, Khazanie PG, Pories WJ, et al. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 1990;85:1349-1355.
11. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992;15:318-368.
12. Yki-Järvinen H. Pathogenesis of non-insulin-dependent diabetes mellitus. Lancet 1994;343:91-95.
13. Meltzer AA, Everhart JE. Association between diabetes and elevated serum alanine aminotransferase activity among Mexican Americans. Am J Epidemiol 1997;146:565-571.
14. Erbey JR, Silberman C, Lydick E. Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes. Am J Med 2000;109:588-590.
15. Ikai E, Ishizaki M, Suzuki Y, Ishida M, Noborizaka Y, Yamada Y. Association between hepatic steatosis, insulin resistance and hyper-insulinemia as related to hypertension in alcohol consumers and obese people. J Hum Hypertens 1995;9:101-105.
16. Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 1998;21:732-737.
17. Shinchi K, Kono S, Honjo S, Todoroki I, Sakurai Y, Imanishi K, et al. Obesity and adenomatous polyps of the sigmoid colon. Jpn J Cancer Res 1994;85:479-484.
18. Kono S, Shinchi K, Todoroki I, Honjo S, Sakurai Y, Wakabayashi K, et al. Gallstone disease among Japanese men in relation to obesity, glucose intolerance, exercise, alcohol use, and smoking. Scand J Gastroenterol 1995;30:372-376.
19. Sasazuki S, Kono S, Todoroki I, Honjo S, Sakurai Y, Wakabayashi K, et al. Impaired glucose tolerance, diabetes mellitus, and gallstone disease: an extended study of male self-defense officials in Japan. Eur J Epidemiol 1999;15:245-251.
20. Honjo S, Kono S, Coleman MP, Shinchi K, Sakurai Y, Todoroki I, et al. Coffee consumption and serum aminotransferases in middle-aged Japanese men. J Clin Epidemiol 2001;54:823-829.
21. Alberti KGMM, Zimmet PZ, for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complication. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetes Med 1998;15:539-553.
22. Karmen A, Wróblewski F, LaDue JS. Transaminase activity in human blood. J Clin Invest 1955;35:126-133.
23. Szasz G. A kinetic photometric method for serum-glutamyl transpeptidase. Clin Chem 1969;15:124-136.
24. Thulstrup AM, Norgard B, Steffensen FH, Vilstrup H, Sorensen HT, Lauritzen T. Waist circumference and body mass index as predictors of elevated alanine transaminase in Danes aged 30 to 50 years. Dan Med Bull 1999;46:429-431.
25. Holbrook TL, Barrett-Connor E, Wingard DL. A prospective population-based study of alcohol use and non-insulin-dependent diabetes mellitus. Am J Epidemiol 1990;132:902-909.
26. Kao WHL, Puddey IB, Boland LB, Watson RL, Brancati FL. Alcohol consumption and the risk of type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. Am J Epidemiol 2001;154:748-758.
27. Will JC, Galuska DA, Ford ES, Mokdad A, Calle EE. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int J Epidemiol 2001;30:540-546.
28. Steffensen FH, Sorensen HT, Brock A, Vilstrup H, Lauritzen T. Alcohol consumption and serum liver-derived enzymes in a Danish population aged 30-50 years. Int J Epidemiol 1997;26:92-99.
29. Whitehead TP, Robinson D, Allaway SL. The effects of cigarette smoking and alcohol consumption on serum liver enzyme activities: a dose-related study in men. Ann Clin Biochem 1996;33:530-535.
30. Sherlock S, Dooley J. Diseases of the liver and biliary system. 9th ed. Oxford: Blackwell Scientific, 1993.
31. World Health Organization Expert Committee on Diabetes Mellitus. World Health Organization Tech Rep Ser 1980:646.
32. Sekikawa A, Sugiyama K, Tominaga M, Manaka H, Takahashi K, Sasaki H, et al. Prevalence of diabetes and impaired glucose tolerance in Funagata area, Japan. Diabetes Care 1993;16:570-574.
33. Ohmura T, Ueda K, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, et al. Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama study. Diabetologia 1993;36:1198-1203.
34. Tankurt E, Biberoglu S, Ellidokuz E, Hekimsoy Z, Akpinar H, Comlekci A, et al. Hyperinsulinemia and insulin resistance in non-alcoholic steatohepatitis. J Hepatol 1999;31:963.
35. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450-455.
36. Cömert B, Mas MR, Erdem H, Dinc A, Saglamkaya U, Cigerim M, et al. Insulin resistance in non-alcoholic steatohepatitis. Dig Liver Dis 2001;33:353-358.
37. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001;50:1844-1850.
38. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121:91-100.
39. Willner IR, Waters B, Patil SR, Reuben A, Morelli J, Riely CA. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 2001;96:2957-2961.
40. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002;35:367-372.
41. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002;35:373-379.